Abstract
With a rapidly global population, there is a critical need to enhance food production and waste management. This necessity is driving opportunities for sustainable integrated food chains committed to biovalorization and circular bioeconomic practices. One approach that aligns with this vision relies on sustainable tissue engineering, which offers opportunities to leverage food systems in the search for natural biomaterials from agricultural waste. In this perspective, we propose utilizing common meat waste sources, often associated with a high environmental footprint, to develop tissue graft models. These models reduce agricultural waste, decrease the reliance on animal testing, and support both biovalorization and medical innovation. Specifically, we explore a unique approach to generate corneal transplantation models completely from discarded components of the meat food chain, using the eyes and bladders. This strategy involves creating keratoplasty models by reseeding the decellularized extracellular matrix (dECM), encompassing three major corneal regions: the epithelium, stroma, and endothelium. Interestingly, these scaffolds can be recellularized with cellular lineages derived from stem niches harvested from urine. This approach integrates waste management with regenerative medicine, fostering sustainable advancements in tissue engineering.
Introduction
Agri-food systems utilize various extraction, processing, storage, and distribution practices to support human consumption. Unfortunately, the recent pandemic, rapid population growth, climate change, ecological disasters, and political tensions emphasize a need for reassessments (McGreevy et al., 2022). These reassessments emphasize sustainability and waste management to help avert future disasters and conflicts.
These approaches aim to enhance food production through better-integrated food chains committed to biovalorization and circular bioeconomic practices. Several studies have outlined how sustainable integrated food chains can, in general, drive the conversion of organic waste and biomass into valuable products and consumption cycles (Ashokkumar et al., 2022) and specifically advance tissue engineering that supports cultured meat (Mancini et al., 2022; Manning et al., 2023; Perreault et al., 2023; Ramachandraiah, 2021; Hong et al., 2021) and biomaterials research (Khan et al., 2023; Tarafdar et al., 2021; Limeneh et al., 2022; Shibru et al., 2024).
Within the past decade, it was stated that roughly 10% of the 285 million vision-impaired people worldwide suffer from corneal opacities (He et al., 2020). Furthermore, roughly 2 million of the world’s 39.3 million population who are visually impaired can trace their cause of ailment to a corneal opacity (Wang E. Y. et al., 2023). The increasing prevenance of diseases, fungal, bacterial, viral, and metabolic conditions also contribute to chronic and end-stage conditions.
For instance, the rapid increase in the prevalence of diabetes mellitus has led to more cases of keratopathy and corneal neuropathy. Paradoxically, the SARS-CoV-2/COVID-19 vaccination presented adverse corneal events such as native corneal fiber neuropathy in COVID-19 patients (Yin et al., 2022). Such identified health issues underscore the necessity for further research to address corneal impairment.
As a means to simultaneously find novel solutions to these pressing issues, in this perspective, we propose utilizing common meat waste sources, often associated with a high environmental footprint, to develop tissue graft models. These models aim to reduce agricultural waste, decrease the reliance on animal testing, and support both biovalorization and medical innovation as we strive to address the global shortage of transplantable corneal tissues.
The role of biomaterials in addressing the corneal transplantation shortage
Biomaterials research involves the development of novel components and cutting-edge synthesis and fabrication technologies for industrial and clinical applications. A major clinical application is the development of transplantable organs and tissues, such as the cornea, to help the estimated 12.7 million worldwide who need keratoplasty (Liu et al., 2022). Recent evidence suggests the potential to improve xenografting technologies and models. Such models can be generated from repurposed human and animal ocular tissues, offering a novel pathway to utilize discarded by-products of the food industry for therapeutic purposes (Pantic et al., 2023; Wang et al., 2022; Wang et al., 2023a; Shibru et al., 2023), as illustrated in Figure 1.
FIGURE 1
Advances in corneal substitutes
The cornea is a thin, transparent tissue for ophthalmic protection and light transmission. Prolonged exposure to natural elements, combined with the increasing prevalence of diseases, can cause irreversible complications, such as clouding, distortion, scarring, and eventual blindness. Current treatments for corneal repair include eye drops, ointments, oral medications, intraocular ring implantations, and, ultimately, transplantation. Although transplantation is the ideal correction for end-stage conditions, the limited availability of graft tissues necessitates new treatment avenues.
Significant advances in regenerative medicine have led to the development of corneal substitutes from bovine, caprine, ovine, porcine, and human cadaveric tissues through techniques like additive manufacturing (Jia et al., 2023), decellularized extracellular matrix (dECM) (Nara et al., 2016; Polisetti et al., 2021), and stem cell technologies (El Zarif et al., 2020). Recently, the potential of non-invasively sourced stem cells, including menstrual, adipose, and urine-derived cells (UCs), has been investigated for regenerative applications. UCs are highly proliferative and represent an unlimited and utterly non-invasive resource. These cells can be reprogrammed into iPSCs and differentiated into various cell lineages for corneal tissue engineering and regeneration (Jing et al., 2019).
Repurposing slaughterhouse waste for sustainable keratoplasty models
The cornea serves a dual role: it transmits light to the rod and cone cells and is a barrier against debris, bacteria, and other foreign bodies. Structurally, the cornea consists of three main layers-the epithelium, stroma, and endothelium - and two interfaces, namely, the Bowman’s layer and Descemet’s membrane, as shown in Figure 2. The epithelium, the outermost layer, through its inner basal cells, middle wing cells, and superficial squamous cells, enhances the eye’s barrier and refractive abilities (Yam et al., 2020). Additionally, this multilayered compartment accommodates bone marrow-derived ocular surface Langerhans antigen-presenting cells that regulate immunoreception and immunodefense.
FIGURE 2
Since the cornea is the eye’s outermost layer, it is especially prone to injuries. Trauma to the cornea can present as abrasions and keratitis, with more advanced damage causing corneal clouding, distortion, scarring, and eventual blindness. While it heals from minor injuries with the migration, proliferation, and differentiation of healthy peripheral epithelial cells, keratinocytes, and endothelial cells, its avascular nature limits innate wound healing due to the decreased access to nutrients and immune cells necessary for repair. Consequently, more severe injuries require external treatment like eye drops containing antibiotics, steroids, oral medications, phototherapeutic keratectomy, and keratoplasty.
Corneal bioengineering: generating scaffolds from discarded eyes and reprogramming waste-derived stem cells
The dECM for corneal scaffolding
Advances in tissue engineering and regenerative medicine have led to studies investigating the use of the dECM as a tissue scaffold, as shown in Figure 3. Theoretically, these scaffolds maintain the ideal structural environment of the tissue and maintain the levels of endogenous cytokines and growth factors. The interaction between these elements of the ECM matrix with the surrounding cells plays a significant role in tissue differentiation, migration, adhesion, and proliferation (Chan and Leong, 2008; Chen et al., 2024). Furthermore, hydrogels that mimic ECM were shown to promote the proper proliferation and differentiation of ocular stem cells (Lu et al., 2024). Heparin sulfate is a vital component of the ocular ECM that promotes cell migration and proliferation. Other glycosaminoglycans, as well as different collagen types, have also been indicated to contribute to the ECM’s ability to promote cell differentiation (Yang et al., 2025). Analogs of heparin sulfate have shown promising clinical applications in restoring damaged ECM and, hence, restoring vision in patients suffering from corneal damage (Mahdavi et al., 2020). Providing an ECM-based scaffold with the required differentiation factors could play a vital role in advancing corneal repair and transplantation.
FIGURE 3
For instance, repurposing tissue waste from bovine animals has proven a worthy avenue to explore. In recent studies, corneas are collected from discarded sheep eyes (Pantic et al., 2023; Ali et al., 2024; Wang et al., 2023b), where they are subsequently decellularized to remove innate cellular components from the scaffolds. Then, the samples are immersed in glycerol to restore the opacity of the cornea. The scaffolds were tested and shown to have preserved ocular transparency, transmittance, and ECM microstructures necessary for proper corneal function. The result is a successfully decellularized corneal scaffold that maintains its microscopic integrity (Ahearne et al., 2020a). The unique value behind decellularized scaffolds is that they furnish an anatomical environment equipped with suitable cues for cell proliferation, differentiation, and organization (GarcÃa-Gareta et al., 2020). Comparable studies involving human tissues have also provided evidence to support effective corneal decellularization/recellularization (Polisetti et al., 2021).
Urine-derived cells (UCs) and their potential
One can argue that the ideal stem cells to repair corneal damage are the limbal epithelial stem cells and corneal stromal stem cells (Nurković et al., 2020). However, the limited availability, high costs, and challenges with cell isolation probe us to find other alternatives. In the past, biomaterials such as menstrual blood have been used to isolate stem cells; hence, we considered a more available and comparably radical biomaterial (Sanchez-Mata and Gonzalez-Muñoz, 2021). Urine, a non-invasive and potentially unlimited resource, contains several cells that can be reprogrammed to induce pluripotency and potentially support differentiation into cells of all three corneal germ layers (Jing et al., 2019).
Urine-derived cells primarily originate from the renal, bladder, and urethral epithelial linings and collectively comprise various cell types, including renal, blood, and immune cells. They also include an adult form of stem cells, whose differentiation potential is generally considered less than that of pluripotent stem cells (Sato et al., 2019).
UC isolation, characterization and utilization
From a clinical perspective, such samples can be obtained from a prospective recipient to isolate the target cells. For this process, samples can be collected from routine urination or using a clean catch method to prevent the transmission of germs from the genitals (Diviney and Jaswon, 2021). For this latter process, it is advised to clean the genitals effectively, allow a small amount of initial urine to flow into the toilet, and then stop the flow and place the sterile collection tube to collect from the second stream of urine. The sterilized containers should contain antibiotics to inhibit bacterial growth (Burdeyron et al., 2020). The samples can be centrifuged at room temperature. Afterward, the supernatant can be aspirated and discarded to isolate the cell pellets. The pellets can be gently responded with sterile PBS and centrifuged again to remove loosely bound debris in the subsequent supernatant. The final pellet can then be cultured for downstream application, such as expansion, multi-/pluripotency verification, and differentiation with collagen- or gelatin-coated dishes/flasks, as extensively outlined in our previous work (Corridon et al., 2025).
Notably, within 7–8 days, urine-derived cell colonies can be formed in the plate (Lang et al., 2013). Once the UCs are reprogrammed into IPSCs, presented in Figure 4, they must be assessed for their pluripotency, which can be done using immunostaining techniques for various biomarkers, including crucial transcription factors like Sox2, Klf4, Nanog, Oct4, and C-myc, as well as surface antigens such as SSEA3/-4, Tra-1-60, and Tra-1-81 (Baghbaderani et al., 2016), as outlined in Figure 5. After isolation and characterization, established differentiation protocols can be applied to derive epithelial, stromal, and endothelial lineages. These methods aligned with existing stem cell and corneal regeneration literature protocols (Corridon et al., 2025). Beyond this, colony expansion follows.
FIGURE 4
FIGURE 5
Corneal decellularization and recellularization
Several approaches, as summarized in Table 1, have been defined throughout the literature to generate dECM scaffolds (Wang et al., 2023b; Procházková et al., 2024; Ahearne et al., 2020b; Fernández-Pérez and Ahearne, 2020; Isidan et al., 2019; Murtaza et al., 2024). These methods generally combine chemical and mechanical treatments, whereby extracted corneas can be agitated in a given agent, and swelling, a natural consequence of the decellularization process, can be limited using osmotic agents (like dextrans and glycerol) to preserve ultrastructural tissue properties. After which, structural and functional assays, like histology and spectroscopy, can be respectfully employed to gauge corneal structure and optical function.
TABLE 1
| Class of agent | Type (examples) | Role in corneal decellularization | Outcome |
|---|---|---|---|
| Detergents | Triton X-100, SDS, SDC, Tween-20/80, CHAPS | Disrupt lipid membranes and lyse cells | Non-ionic detergents (e.g., Triton X-100) preserve ECM; ionic detergents (e.g., SDS) are harsher but more effective for nuclear removal; and non-ionic zwitterionic detergents preserve ECM and transparency |
| Enzymes and Chelators | DNase I, RNase A, Trypsin, EDTA, EGTA | Degrade nucleic acids and disrupt cell–matrix or cell–cell adhesion | Often used after detergents to clean residual cell components; chelators enhance enzymatic access |
| Osmotic Agents | NaCl (hypertonic/hypotonic), deionized water | Induce osmotic shock to rupture cells | Used as pre-treatment, rinse, or in cycles with detergents |
| Chemical Disruptors (Acids/Bases/Oxidizers) | Peracetic acid, HCl, acetic acid, NH4OH, NaOH, H2O2 | Additional lysis, sterilization, or nuclear denaturation | Strong agents; use at low concentrations to avoid ECM and transparency loss |
Summary of the corneal decellularization approaches. This table outlines commonly used classes of decellularization agents in corneal tissue processing, providing representative examples, their functional roles, and practical considerations, particularly regarding extracellular matrix (ECM) preservation and optical transparency.
In comparison, for scaffold recellularization, various additional aspects must be considered, including cell seeding density, incubation periods, and compartment-specific reseeding of epithelial, stromal, and endothelial layers. Various approaches have been evaluated, and novel ones are being considered; however, as we have previously postulated, we believe a combination of approaches will be needed to support the regeneration of dedicated epithelial and endothelial layers while simultaneously facilitating sparse yet widespread cell populations in the stroma. Specifically, various cell plating- and injection-based reseeding techniques can be applied to reintroduce the various cell lineages into their respective compartments. Chemotactic assays to gauge and support cellular migration in regions like the stroma (Kabak et al., 2020), and retraction methods within the endothelium and epithelium to effectively control cell adhesion and localization within the compartments (De Pieri et al., 2021). Interestingly, it is also important to highlight the use of computational modeling to guide and validate compartment-specific reseeding and cell migration.
Evaluations of ocular function and biomarker-based assessments
Tracking cellular differentiation using biomarkers
To observe the transitions of iPSCs into the specific corneal cell phenotype, we can track the cell-specific markers expressed by each cell type. Corneal epithelial cell markers include cytokeratin 3 (K3), cytokeratin 12 (k12), lumican, and aldehyde dehydrogenase (ALDH) (Harkin et al., 2015; Hashmani et al., 2013; Català et al., 2021). Corneal stromal cell markers include CD34, keratocans, and lumican (Li et al., 2021). Finally, corneal endothelial cell markers include N-cadherin, zona occludens-1, and Na/K-ATPase (Ju et al., 2012; He et al., 2016; Thériault et al., 2018). These markers can be identified through Western blotting or immunofluorescence. Biomarkers can be used to test the structural integrity of the graft and ensure that appropriate cells are being expressed in their locations.
Assessing optical and structural properties of the bioengineered cornea
The eye’s cornea has the unique property of being transparent; we can measure light transmission to assess the functionality of our transplanted stem cells. At a microscopic scale, this characteristic is determined by the lack of scatter caused by corneal cells or other structures that might induce local alterations in the refractive index. On a nanoscopic level, it’s characterized by the absence of pigments or blood vessels and by the specific structure and arrangement of collagen fibrils within the lamellae (Meek and Knupp, 2015; Corridon et al., 2006). We can measure light transmission ex vivo and in vivo. The keratografts post-decellularization (Pantic et al., 2023; Wang et al., 2023b) and post-recellularization can be assessed for transparency and optical transmittance (Polisetti et al., 2021). These studies can provide insight into general ECM disruption and specific collagen fiber disorganization. Fluorescent-based microscopic evaluations and computational approaches can provide insight into cellular migration, retraction, and fiber orientation/alignment (Corridon et al., 2022; Shakeel and Corridon, 2022; Zhang et al., 2023).
Challenges and future perspectives
After reseeding the dECM scaffold, the ideal result is a graft that mimics the natural eye and nurtures a microenvironment supporting long-term structure and function. However, a few limitations exist with using a decellularized scaffold and IPSCs for recellularization. Once the scaffold is seeded, it is hoped that intrinsic bioactive factors retained within the ECM can direct cell migration, proliferation, and differentiation. Although inducible through factors and trackable through immunofluorescence, it may be challenging to wholly control the migration and differentiation of the IPSCs. Additionally, the integrity of the ECM could be compromised via decellularization. However, the structural and functional integrity of the scaffold can be monitored and gauged through various well-known assays.
Moreover, the ECM scaffold must contain the correct tracts and pathways to facilitate the migration of native cells, such as nerves or immune cells, to reinnervate and populate our graft. A possible complication of this would be excess angiogenesis in our graft. The native cornea expresses certain factors that modulate and limit vascularization. However, cells that populate our scaffold, whether exogenous or native, risk expressing angiogenic factors that will result in blood vessel growth in the cornea, ultimately leading to reduced transparency.
Conclusion
This approach relies on the dECM as a scaffold for xenografting, which arguably provides one of the most suitable environments for corneal regeneration. Likewise, with the bladders, the outline approach builds on previous and source pluripotent-induced stem cells from the urine to generate various cellular lineages to repopulate the three major corneal regions: the epithelium, stroma, and endothelium. The proposed pathway can potentially help develop patient-specific approaches for disease modeling, drug discovery, and further pathogenesis research while minimizing and valorizing agri-food waste.
Statements
Data availability statement
The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author.
Author contributions
AM: Conceptualization, Writing – original draft, Writing – review and editing. ZH: Conceptualization, Writing – original draft, Writing – review and editing. PC: Conceptualization, Data curation, Formal Analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review and editing.
Funding
The author(s) declare that financial support was received for the research and/or publication of this article. This project was supported by funds granted to PC from Khalifa University of Science and Technology, grant numbers ESIG-2023-005 (8474000476) and KU-9622 (8474000655), the Center for Biotechnology, and the College of Medicine and Health Sciences. The project was also funded by support granted to PC from the Abu Dhabi Automated Slaughterhouse, Municipality of the City of Abu Dhabi.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The authors declare that Generative AI was used in the creation of this manuscript. During the preparation of this work, the author(s) used ChatGPT 4.0 and Grammarly to reduce spelling and grammar errors. After using this tool/service, the author(s) reviewed and edited the content as needed and take(s) full responsibility for the content of the publication.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1
AguirreM.EscobarM.Forero AmézquitaS.CubillosD.RincónC.VanegasP.et al (2023). Application of the yamanaka transcription factors Oct4, Sox2, Klf4, and c-myc from the laboratory to the clinic. Genes14, 1697. 10.3390/genes14091697
2
AhearneM. (2020b). Chapter 5 - corneal extracellular matrix decellularization, in Methods in cell biology. Editors CaballeroD.KunduS. C.ReisR. L. (Academic Press), 81–95.
3
AhearneM.Fernández-PérezJ.MastertonS.MaddenP. W.BhattacharjeeP. (2020a). Designing scaffolds for corneal regeneration. Adv. Funct. Mater.30, 1908996. 10.1002/adfm.201908996
4
AliZ. M.WangX.ShibruM. G.AlhosaniM.AlfadhliN.AlnuaimiA.et al (2024). A sustainable approach to derive sheep corneal scaffolds from stored slaughterhouse waste. Regen. Med.19, 303–315. 10.1080/17460751.2024.2357499
5
AshokkumarV.FloraG.VenkatkarthickR.SenthilKannanK.KuppamC.Mary StephyG.et al (2022). Advanced technologies on the sustainable approaches for conversion of organic waste to valuable bioproducts: emerging circular bioeconomy perspective. Fuel324, 124313. 10.1016/j.fuel.2022.124313
6
BaghbaderaniB. A.SyamaA.SivapathamR.PeiY.MukherjeeO.FellnerT.et al (2016). Detailed characterization of human induced pluripotent stem cells manufactured for therapeutic applications. Stem Cell Rev. Rep.12, 394–420. 10.1007/s12015-016-9662-8
7
BurdeyronP.GiraudS.HauetT.SteichenC. (2020). Urine-derived stem/progenitor cells: a focus on their characterization and potential. World J. Stem Cells12, 1080–1096. 10.4252/wjsc.v12.i10.1080
8
Català P.GroenN.DehnenJ. A.SoaresE.van VelthovenA. J. H.NuijtsR. M. M. A.et al (2021). Single cell transcriptomics reveals the heterogeneity of the human cornea to identify novel markers of the limbus and stroma. Sci. Rep.11, 21727. 10.1038/s41598-021-01015-w
9
ChanB. P.LeongK. W. (2008). Scaffolding in tissue engineering: general approaches and tissue-specific considerations. Eur. Spine J.17 (Suppl. 4), 467–479. 10.1007/s00586-008-0745-3
10
ChenZ.DuC.LiuS.LiuJ.YangY.DongL.et al (2024). Progress in biomaterials inspired by the extracellular matrix. Giant19, 100323. 10.1016/j.giant.2024.100323
11
CorridonP.AscázubiR.KrestC.WilkeI. (2006). Time-domain terahertz spectroscopy of artificial skin. SPIE6080. 10.1117/12.646632
12
CorridonP. R.MobinA.HashemZ.PaunovicJ.ValjarevicS.PanticI. V. (2025). Sustainable keratoplasty models using agri-food waste: a hypothesis for transforming biowaste into biomaterials for tissue engineering research. Front. Sustain. Food Syst.9, 1564425. 10.3389/fsufs.2025.1564425
13
CorridonP. R.WangX.ShakeelA.ChanV. (2022). Digital technologies: advancing individualized treatments through gene and cell therapies, pharmacogenetics, and disease detection and diagnostics. Biomedicines10, 2445. 10.3390/biomedicines10102445
14
De PieriA.RochevY.ZeugolisD. I. (2021). Scaffold-free cell-based tissue engineering therapies: advances, shortfalls and forecast. npj Regen. Med.6, 18. 10.1038/s41536-021-00133-3
15
DivineyJ.JaswonM. S. (2021). Urine collection methods and dipstick testing in non-toilet-trained children. Pediatr. Nephrol.36, 1697–1708. 10.1007/s00467-020-04742-w
16
El ZarifM.Alió del BarrioJ. L.Arnalich-MontielF.De MiguelM. P.MakdissyN.AlióJ. L. (2020). Corneal stroma regeneration: new approach for the treatment of cornea disease. Asia-Pacific J. Ophthalmol.9, 571–579. 10.1097/APO.0000000000000337
17
Fernández-PérezJ.AhearneM. (2020). Decellularization and recellularization of cornea: progress towards a donor alternative. Methods171, 86–96. 10.1016/j.ymeth.2019.05.009
18
GarcÃa-GaretaE.AbduldaiemY.SawadkarP.KyriakidisC.LaliF.GrecoK. V. (2020). Decellularised scaffolds: just a framework? Current knowledge and future directions. J. Tissue Eng.11, 2041731420942903. 10.1177/2041731420942903
19
HarkinD. G.FoynL.BrayL. J.SutherlandA. J.LiF. J.CroninB. G. (2015). Concise reviews: can mesenchymal stromal cells differentiate into corneal cells? A systematic review of published data. Stem Cells33, 785–791. 10.1002/stem.1895
20
HashmaniK.BranchM. J.SidneyL. E.DhillonP. S.VermaM.McIntoshO. D.et al (2013). Characterization of corneal stromal stem cells with the potential for epithelial transdifferentiation. Stem Cell Res. Ther.4, 75. 10.1186/scrt226
21
HeY.NieA.PeiJ.JiZ.JiaJ.LiuH.et al (2020). Prevalence and causes of visual impairment in population more than 50 years old: the Shaanxi Eye Study. Med. Baltim.99, e20109. 10.1097/md.0000000000020109
22
HeZ.ForestF.GainP.RageadeD.BernardA.AcquartS.et al (2016). 3D map of the human corneal endothelial cell. Sci. Rep.6, 29047. 10.1038/srep29047
23
HongT. K.ShinD. M.ChoiJ.DoJ. T.HanS. G. (2021). Current issues and technical advances in cultured meat production: a review. Food Sci. Anim. Resour.41, 355–372. 10.5851/kosfa.2021.e14
24
IsidanA.LiuS.LiP.LashmetM.SmithL. J.HaraH.et al (2019). Decellularization methods for developing porcine corneal xenografts and future perspectives. Xenotransplantation26, e12564. 10.1111/xen.12564
25
JiaS.BuY.LauD.-S. A.LinZ.SunT.LuW. W.et al (2023). Advances in 3D bioprinting technology for functional corneal reconstruction and regeneration. Front. Bioeng. Biotechnol.10, 1065460. 10.3389/fbioe.2022.1065460
26
JingY.ZhouY.WangC.LiuJ.GuoY.MaoS.et al (2019). Establishment of a non-integrate iPS cell line CSUASOi002-A, from urine-derived cells of a female patient with macular corneal dystrophy carrying compound heterozygous CHST6 mutations. Stem Cell Res.41, 101598. 10.1016/j.scr.2019.101598
27
JuC.ZhangK.WuX. (2012). Derivation of corneal endothelial cell-like cells from rat neural crest cells in vitro. PLoS One7, e42378. 10.1371/journal.pone.0042378
28
KabakE. C.Fernández-PérezJ.AhearneM. (2020). Development and validation of a 3D in vitro model to study the chemotactic behavior of corneal stromal fibroblasts. Methods Mol. Biol.2145, 185–196. 10.1007/978-1-0716-0599-8_13
29
KhanR. L.KhraibiA. A.DumeeL. F.CorridonP. R. (2023). From waste to wealth: repurposing slaughterhouse waste for xenotransplantation. Front. Bioeng. Biotechnol.11, 1091554. 10.3389/fbioe.2023.1091554
30
LangR.LiuG.ShiY.BharadwajS.LengX.ZhouX.et al (2013). Self-renewal and differentiation capacity of urine-derived stem cells after urine preservation for 24 hours. PLoS One8, e53980. 10.1371/journal.pone.0053980
31
LiS.CuiZ.GuJ.WangY.TangS.ChenJ. (2021). Effect of porcine corneal stromal extract on keratocytes from SMILE-derived lenticules. J. Cell. Mol. Med.25, 1207–1220. 10.1111/jcmm.16189
32
LimenehD. Y.TesfayeT.AyeleM.HusienN. M.FeredeE.HaileA.et al (2022). A comprehensive review on utilization of slaughterhouse by-product: current status and prospect. Sustainability14, 6469. 10.3390/su14116469
33
LiuS.WongY. L.WalkdenA. (2022). Current perspectives on corneal transplantation. Clin. Ophthalmol.16, 631–646. 10.2147/opth.s289359
34
LuP.RuanD.HuangM.TianM.ZhuK.GanZ.et al (2024). Harnessing the potential of hydrogels for advanced therapeutic applications: current achievements and future directions. Signal Transduct. Target. Ther.9, 166. 10.1038/s41392-024-01852-x
35
MahdaviS. S.AbdekhodaieM. J.MashayekhanS.Baradaran-RafiiA.DjalilianA. R. (2020). Bioengineering approaches for corneal regenerative medicine. Tissue Eng. Regen. Med.17, 567–593. 10.1007/s13770-020-00262-8
36
ManciniM. C.AntonioliF. (2022). Chapter 19-the future of cultured meat between sustainability expectations and socio-economic challenges, in Future foods. Editor BhatR. (Academic Press), 331–350.
37
ManningL.DooleyJ. J.DunsfordI.GoodmanM. K.MacMillanT. C.MorgansL. C.et al (2023). Threat or opportunity? An analysis of perceptions of cultured meat in the UK farming sector. Front. Sustain. Food Syst.7. 10.3389/fsufs.2023.1277511
38
McGreevyS. R.RupprechtC. D. D.NilesD.WiekA.CarolanM.KallisG.et al (2022). Sustainable agrifood systems for a post-growth world. Nat. Sustain.5, 1011–1017. 10.1038/s41893-022-00933-5
39
MeekK. M.KnuppC. (2015). Corneal structure and transparency. Prog. Retin Eye Res.49, 1–16. 10.1016/j.preteyeres.2015.07.001
40
MurtazaZ. F.Abou FaresA.AlMuhairiF.PaunovicJ.ValjarevicS.PanticI. V.et al (2024). A bioengineered model for reinnervating the decellularized extracellular matrix of corneal scaffolds. Med. Hypotheses185, 111315. 10.1016/j.mehy.2024.111315
41
NaraS.ChameettachalS.MidhaS.MurabS.GhoshS. (2016). Preservation of biomacromolecular composition and ultrastructure of a decellularized cornea using a perfusion bioreactor. RSC Adv.6, 2225–2240. 10.1039/c5ra20745b
42
NurkovićJ. S.VojinovićR.DolićaninZ. (2020). Corneal stem cells as a source of regenerative cell-based therapy. Stem Cells Int.2020, 1–11. 10.1155/2020/8813447
43
PanticI. V.CumicJ.ValjarevicS.ShakeelA.WangX.VuriviH.et al (2023). Computational approaches for evaluating morphological changes in the corneal stroma associated with decellularization. Front. Bioeng. Biotechnol.11, 1105377. 10.3389/fbioe.2023.1105377
44
PerreaultL. R.ThydenR.KlosterJ.JonesJ. D.NunesJ.PatmanidisA. A.et al (2023). Repurposing agricultural waste as low-cost cultured meat scaffolds. Front. Food Sci. Technol.3. 10.3389/frfst.2023.1208298
45
PolisettiN.SchmidA.Schlötzer-SchrehardtU.MaierP.LangS. J.SteinbergT.et al (2021). A decellularized human corneal scaffold for anterior corneal surface reconstruction. Sci. Rep.11, 2992. 10.1038/s41598-021-82678-3
46
ProcházkováA.PoláchováM.DÃtÄ›J.NetukováM.StudenýP. (2024). Chemical, physical, and biological corneal decellularization methods: a review of literature. J. Ophthalmol.2024, 1191462. 10.1155/2024/1191462
47
RamachandraiahK. (2021). Potential development of sustainable 3D-printed meat analogues: a review. Sustainability13, 938. 10.3390/su13020938
48
Sanchez-MataA.Gonzalez-MuñozE. (2021). Understanding menstrual blood-derived stromal/stem cells: definition and properties. Are we rushing into their therapeutic applications?iScience24, 103501. 10.1016/j.isci.2021.103501
49
SatoM.TakizawaH.NakamuraA.TurnerB. J.ShabanpoorF.AokiY. (2019). Application of urine-derived stem cells to cellular modeling in neuromuscular and neurodegenerative diseases. Front. Mol. Neurosci.12, 297. 10.3389/fnmol.2019.00297
50
SchmidtR.PlathK. (2012). The roles of the reprogramming factors Oct4, Sox2 and Klf4 in resetting the somatic cell epigenome during induced pluripotent stem cell generation. Genome Biol.13, 251. 10.1186/gb-2012-13-10-251
51
ShakeelA.CorridonP. R. (2022). Mitigating challenges and expanding the future of vascular tissue engineering-are we there yet?Front. Physiol.13, 1079421. 10.3389/fphys.2022.1079421
52
ShibruM. G.AliZ. M.AlaliS.AlkhooriH.CorridonP. R. (2023). Keeping an eye on sustainable regeneration. Regen. Med.18 (12), 891–895. 10.2217/rme-2023-0142
53
ShibruM. G.AliZ. M.AlmansooriA. S.PaunovicJ.PanticI. V.CorridonP. R. (2024). Slaughterhouse waste: a unique and sustainable source for dECM-based bioinks. Regen. Med.19 (3), 113–118. 10.2217/rme-2023-0194
54
TarafdarA.GaurV. K.RawatN.WankhadeP. R.GaurG. K.AwasthiM. K.et al (2021). Advances in biomaterial production from animal derived waste. Bioengineered12, 8247–8258. 10.1080/21655979.2021.1982321
55
ThériaultM.GendronS. P.BrunetteI.RochetteP. J.ProulxS. (2018). Function-related protein expression in fuchs endothelial corneal dystrophy cells and tissue models. Am. J. Pathology188, 1703–1712. 10.1016/j.ajpath.2018.03.014
56
WangE. Y.KongX.WolleM.GasquetN.SsekasanvuJ.MariottiS. P.et al (2023). Global trends in blindness and vision impairment resulting from corneal opacity 1984-2020: a meta-analysis. Ophthalmology130, 863–871. 10.1016/j.ophtha.2023.03.012
57
WangX.ChanV.CorridonP. R. (2022). Decellularized blood vessel development: current state-of-the-art and future directions. Front. Bioeng. Biotechnol.10, 951644. 10.3389/fbioe.2022.951644
58
WangX.ElbahrawiR. T.AbdukadirA. M.AliZ. M.ChanV.CorridonP. R. (2023a). A proposed model of xeno-keratoplasty using 3D printing and decellularization. Front. Pharmacol.14, 1193606. 10.3389/fphar.2023.1193606
59
WangX.ShakeelA.SalihA. E.VuriviH.DaoudS.DesideryL.et al (2023b). A scalable corneal xenograft platform: simultaneous opportunities for tissue engineering and circular economic sustainability by repurposing slaughterhouse waste. Front. Bioeng. Biotechnol.11, 1133122. 10.3389/fbioe.2023.1133122
60
YamG. H. F.RiauA. K.FunderburghM. L.MehtaJ. S.JhanjiV. (2020). Keratocyte biology. Keratocyte Biol. Exp. Eye Res.196, 108062. 10.1016/j.exer.2020.108062
61
YangX.MistryM.ChenA. D.ChanB. P. (2025). Tailoring extracellular matrix niches: impact of glycosaminoglycan content on multiple differentiation of human mesenchymal stem cells. Biomaterials318, 123130. 10.1016/j.biomaterials.2025.123130
62
YinX.LiQ.McNuttP. M.ZhangY. (2022). Urine-derived stem cells for epithelial tissues reconstruction and wound healing. Pharmaceutics14, 1669. 10.3390/pharmaceutics14081669
63
ZhangM.YangF.HanD.ZhangS. Y.DongY.LiX.et al (2023). 3D bioprinting of corneal decellularized extracellular matrix: GelMA composite hydrogel for corneal stroma engineering. Int. J. Bioprint9, 774. 10.18063/ijb.774
Summary
Keywords
sustainable tissue engineering, meat waste, decellularized ECM (dECM), urine-derived cells (UCs), recellularization, keratoplasty
Citation
Mobin A, Hashem Z and Corridon PR (2025) Transforming meat waste into sustainable corneal keratoplasty models. Front. Bioeng. Biotechnol. 13:1572127. doi: 10.3389/fbioe.2025.1572127
Received
07 February 2025
Accepted
04 April 2025
Published
14 April 2025
Volume
13 - 2025
Edited by
Maria Angelica Miglino, Universidade de MarÃlia, Brazil
Reviewed by
Beatriz Soledad, Andrés Bello Catholic University, Venezuela
Updates
Copyright
© 2025 Mobin, Hashem and Corridon.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Peter R. Corridon, peter.corridon@ku.ac.ae
†These authors share first authorship
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.